| No. | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 21 | Step | 101813 | 2022-12-02 | 185 |
| 22 | Exempt (if applicable) | 101811 | 2022-12-02 | 191 |
| 23 | Expanded Access Status | 101810 | 2022-12-02 | 191 |
| 24 | Expanded Access | 101809 | 2022-12-02 | 185 |
| 25 | IND/IDE: Expiration Date | 101807 | 2022-12-02 | 203 |
| 26 | FDA Approval Date | 101806 | 2022-12-02 | 221 |
| 27 | IND/IDE Submit Date | 101805 | 2022-12-02 | 182 |
| 28 | Grantor | 101804 | 2022-12-02 | 174 |
| 29 | NCI/NIH Institution | 101803 | 2022-12-02 | 178 |
| 30 | Investigational Drug/Device | 101800 | 2022-12-02 | 179 |
| 31 | Fund Account No. | 101797 | 2022-11-29 | 242 |
| 32 | Sponsor Protocol No. | 101796 | 2022-11-29 | 178 |
| 33 | Sponsor Type | 101795 | 2022-11-29 | 230 |
| 34 | Staff: Stop Reason | 101793 | 2022-11-29 | 193 |
| 35 | Staff: Stop Date | 101792 | 2022-11-29 | 203 |
| 36 | Staff: Start Date | 101791 | 2022-11-29 | 197 |
| 37 | Protocol Staff Role | 70715 | 2022-11-29 | 283 |
| 38 | Managment Group | 101788 | 2022-11-29 | 229 |
| 39 | Toxicity Scheme | 24235 | 2022-11-25 | 279 |
| 40 | IRB Committee | 101848 | 2022-11-17 | 165 |
Not finding what you are looking for? Suggest a new document be created.